Aminofurazans as potent inhibitors of AKT kinase
Rouse, M.B., Seefeld, M.A., Leber, J.D., McNulty, K.C., Sun, L., Miller, W.H., Zhang, S., Minthorn, E.A., Concha, N.O., Choudhry, A.E., Schaber, M.D., Heerding, D.A.(2009) Bioorg.Med.Chem.Lett. 19: 1508-1511
- PubMed: 19179070 
- DOI: 10.1016/j.bmcl.2009.01.002
- Primary Citation of Related Structures:  
- PubMed Abstract: 
AKT inhibitors containing an imidazopyridine aminofurazan scaffold have been optimized. We have previously disclosed identification of the AKT inhibitor GSK690693, which has been evaluated in clinical trials in cancer patients. Herein we describe rec ...